CONMED Corporation (NYSE: CNMD ) delivered adjusted earnings per share of 98 cents in the second quarter of 2024, which beat the Zacks Consensus Estimate of 92 cents by 6.5%. The bottom line improved 18.1% from the year-ago quarter''s level. GAAP EPS for the quarter was 96 cents compared with 43 cents per share in the year-ago period. The company''s shares have lost 14.7% in the past six months against the industry''s rise of 1.5%. The broader S&P 500 Index has gained 11.7% in the same time frame. Image Source: Zacks Investment Research Revenues in Detail CONMED''s revenues totaled $332.1 million, up 4.5% year over year. The top line missed the Zacks Consensus Estimate by 0.7%. At constant exchange rate (CER), revenues increased 5.2%. CNMD''s second-quarter sales were driven by strong growth in the United States as well as international markets. The second quarter witnessed steady surgical volumes. The performance of CONMED''s BioBrace in the foot and ankle space seemed encouraging. Segmental Details Revenues in the Orthopedic Surgery segment totaled $139.5 million, down 0.9% from the year-ago quarter''s level on a reported basis.

https://www.investing.com/news/company-news/piper-sandler-lowers-conmed-shares-target-due-to-ongoing-supply-chain-issues-93CH-3548756

CONMED Corporation (NYSE:NYSE:CNMD) Q2 2024 Earnings Conference Call July 31, 2024 4:30 PM ETCompany ParticipantsCurt Hartman – Chair of the Board,…

Conmed (NYSE: CNMD ) just reported results for the second quarter of 2024. Conmed reported earnings per share of 98 cents. This was above the analyst estimate for EPS of 91 cents. The company reported revenue of $332.10 million. This was 0.07% worse than the analyst estimate for revenue of $332.32 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace Legendary Investor Predicts: “Forget AI… THIS Technology Is the Future” The post CNMD Stock Earnings: Conmed Beats EPS, Misses Revenue for Q2 2024 appeared first on InvestorPlace .

No summary available.

CONMED Corporation (NYSE: CNMD) today announced it will report financial results for the second quarter of 2024 after the market close on Wednesday, July 31, 2024. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. Jetzt den vollständigen Artikel lesen

No summary available.